Keloids - Pipeline Insight, 2021
No. of Pages: 60
Researcher’s, “Keloids - Pipeline Insight, 2021,” report provides comprehensive insights about 8+ companies and 8+ pipeline drugs in Keloids pipeline landscape. It covers the pipeline
|
15-Mar-2021
|
1500
|
Hemochromatosis - Pipeline Insight, 2021
No. of Pages: 60
Researcher’s, “Hemochromatosis - Pipeline Insight, 2021,” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Hemochromatosis pipeline landscape. It covers the pipeline
|
15-Mar-2021
|
1500
|
Osteonecrosis - Pipeline Insight, 2021
No. of Pages: 60
Researcher’s, “Osteonecrosis - Pipeline Insight, 2021,” report provides comprehensive insights about 6+ companies and 6+ pipeline drugs in Osteonecrosis pipeline landscape. It covers the pipeline
|
15-Mar-2021
|
1500
|
Mydriasis - Pipeline Insight, 2021
No. of Pages: 60
Researcher’s, “Mydriasis – Pipeline Insight, 2021,” report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in Mydriasis pipeline landscape. It covers the pipeline
|
15-Mar-2021
|
1500
|
Recurrent anaplastic astrocytomas - Pipeline Insight, 2021
No. of Pages: 60
Researcher’s, “Recurrent anaplastic astrocytomas – Pipeline Insight, 2021,” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Recurrent anaplastic astrocytomas pipeline landscape.
|
15-Mar-2021
|
1500
|
Acute optic neuritis - Pipeline Insight, 2021
No. of Pages: 60
Researcher’s, “Acute optic neuritis - Pipeline Insight, 2021,” report provides comprehensive insights about 2+ companies and 2+ pipeline drugs in Acute optic neuritis pipeline landscape.
|
15-Mar-2021
|
1500
|
Peritoneal Cancer - Pipeline Insight, 2021
No. of Pages: 60
Researcher’s, “Peritoneal Cancer – Pipeline Insight, 2021,” report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in Peritoneal Cancer pipeline landscape. It covers
|
15-Mar-2021
|
1500
|
Tuberous Sclerosis - Pipeline Insight, 2021
No. of Pages: 60
Researcher’s, “Tuberous Sclerosis – Pipeline Insight, 2021,” report provides comprehensive insights about 7+ companies and 7+ pipeline drugs in Tuberous Sclerosis pipeline landscape. It covers
|
15-Mar-2021
|
1500
|
Cerebral Infarction - Pipeline Insight, 2021
No. of Pages: 120
Researcher’s, “Cerebral Infarction – Pipeline Insight, 2021,” report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in Cerebral Infarction pipeline landscape. It covers
|
15-Mar-2021
|
2000
|
Immune Thrombocytopenic Purpura - Pipeline Insight, 2021
No. of Pages: 60
Researcher’s, “Immune Thrombocytopenic Purpura - Pipeline Insight, 2021,” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Immune Thrombocytopenic Purpurapipeline landscape. It
|
15-Mar-2021
|
1500
|
AV-101 - Emerging Insight and Market Forecast - 2030
No. of Pages: 30
“AV-101 - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for Major Depressive Disorder in 7 Major
|
03-Mar-2021
|
3250
|
AXS-05 - Emerging Insight and Market Forecast - 2030
No. of Pages: 30
“AXS-05 - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for Treatment Resistant Depression in 7 Major
|
03-Mar-2021
|
3250
|
BRANEBRUTINIB - Emerging Insight and Market Forecast - 2030
No. of Pages: 30
“BRANEBRUTINIB - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for Sjogren’s syndrome in 7 Major Markets.
|
03-Mar-2021
|
3250
|
EFGARTIGIMOD - Emerging Insight and Market Forecast –-2030
No. of Pages: 30
“EFGARTIGIMOD - Emerging Insight and Market Forecast –-2030” the report provides comprehensive insights about an investigational product for Chronic Inflammatory Demyelinating Syndrome in 7 Major
|
03-Mar-2021
|
3250
|
ESKETAMINE DPI - Emerging Insight and Market Forecast - 2030
No. of Pages: 30
“ESKETAMINE DPI - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for Treatment Resistant Bipolar Depression in
|
03-Mar-2021
|
3250
|
FEZOLINETANT (ESN364) - Emerging Insight and Market Forecast - 2030
No. of Pages: 30
“FEZOLINETANT (ESN364) - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for Vasomotor symptoms in 7 Major
|
03-Mar-2021
|
3250
|
GGS-CIDP - Drug Insight and Market Forecast - 2030
No. of Pages: 30
“GGS-CIDP - Drug Insight and Market Forecast - 2030” report by Researcher outlays comprehensive insights of the product indicated for the treatment of its approved
|
03-Mar-2021
|
3250
|
HYQVIA - Emerging Insight and Market Forecast - 2030
No. of Pages: 30
“HYQVIA - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for Chronic inflammatory demyelinating Syndrome in 7
|
03-Mar-2021
|
3250
|
M254 - Emerging Insight and Market Forecast - 2030
No. of Pages: 30
“M254 - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for Chronic Inflammatory Demyelinating Syndrome in 7
|
03-Mar-2021
|
3250
|
MIJ 821 - Emerging Insight and Market Forecast - 2030
No. of Pages: 30
“MIJ 821 - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for Treatment Resistant Depression in 7
|
03-Mar-2021
|
3250
|
